#United States #San Diego #Evofem Biosciences #SOLOSEC #PHEXXI

Evofem Biosciences Commemorates World Contraception Day

On September 26, the world recognizes World Contraception Day, an occasion aimed at elevating awareness about contraception and ensuring that everyone has access to reproductive choices. Evofem Biosciences, Inc. stands at the forefront of this mission, dedicated to providing innovative contraceptive solutions that empower individuals to take charge of their health and determine their futures.

The day reminds us that millions globally depend on contraceptive methods not merely for pregnancy prevention, but also as a path to control their own bodies and lives. However, access to these essential services is far from uniform across various regions and communities. The demands for greater education, innovation, and destigmatization surrounding contraceptive options persist, highlighting the importance of advocacy on such a significant day.

Evofem's commitment to women's health is evident through their groundbreaking products. Their flagship, PHEXXI®, is notable as the first hormone-free, on-demand contraceptive vaginal gel available. Formulated using lactic acid, citric acid, and potassium bitartrate, PHEXXI offers women a non-hormonal alternative that allows for spontaneous sexual activity without the daily regimen of pills or hormonal side effects. Alongside this, SOLOSEC®, a single-dose oral treatment for bacterial vaginosis and trichomoniasis, further showcases Evofem's dedication to women’s reproductive health.

As Saundra Pelletier, CEO of Evofem Biosciences, articulates, “World Contraception Day is about ensuring that every individual has access to safe, effective, and affordable choices.” The reality that many women do not engage in sexual activity daily calls for contraceptive solutions that accommodate real-life needs—thus, PHEXXI meets that demand. The company proudly advocates for women who’ve experienced adverse effects from conventional hormonal contraceptives, including those who are breastfeeding or who simply prefer not to 'over-medicate' themselves.

Beyond product commercialization, Evofem is deeply invested in awareness initiatives that challenge stigma directly. The **